TTD | Drug: D0MS4Z

Drug General Information
Drug ID	D0MS4Z
Former ID	DNC012076
Drug Name	N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526184]
Formula	C19H31NO2
Canonical SMILES	CCCCCCOC1=CC=C(C=C1)C(=O)NCCC(C)(C)C
InChI	1S/C19H31NO2/c1-5-6-7-8-15-22-17-11-9-16(10-12-17)18(21)20-14-13-19(2,3)4/h9-12H,5-8,13-15H2,1-4H3,(H,20,21)
InChIKey	JPQPUSQXWSSOFH-UHFFFAOYSA-N
PubChem Compound ID	10979664
Target and Pathway
Target(s)	Potassium voltage-gated channel subfamily KQT member 1	Target Info	Inhibitor	[526184]
KEGG Pathway	Adrenergic signaling in cardiomyocytes
	Cholinergic synapse
	Gastric acid secretion
	Pancreatic secretion
	Protein digestion and absorption
	Vibrio cholerae infection
PathWhiz Pathway	Muscle/Heart Contraction
Reactome	Voltage gated Potassium channels
WikiPathways	SIDS Susceptibility Pathways
	Potassium Channels
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	TarBasePathway
References
Ref 526184	J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.
Ref 526184	J Med Chem. 2001 Nov 8;44(23):3764-7.Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information